UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 30, 2012
ALION SCIENCE AND TECHNOLOGY CORPORATION
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 333-89756 | 54-2061691 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1750 Tysons Boulevard
Suite 1300
McLean, VA 22102
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (703) 918-4480
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 3.02 | Unregistered Sales of Equity Securities. |
On September 30, 2012, Alion Science and Technology Corporation (“Alion”) sold approximately $1.1 million worth of its common stock to the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust (the “ESOP Trust”). The price per share to be ascribed to the common stock for this sale will be determined in a valuation of Alion common stock to be performed as of September 30, 2012.
The trustee of the ESOP Trust, State Street Bank & Trust Company, has engaged an independent third-party valuation firm to assist in establishing a value for Alion’s common stock as of September 30, 2012. Management expects the valuation to be completed by November 8, 2012.
The shares of common stock were sold pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933, as amended.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: October 9, 2012 | ALION SCIENCE AND TECHNOLOGY CORPORATION | |||||
| By: | /s/ Barry M. Broadus | |||||
| Name: Barry M. Broadus | ||||||
| Title: Chief Financial Officer | ||||||
3